Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-09-26 | 2020-08-21 | 94858 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-08-21 | 103510 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2020-03-19 | 2021-02-11 | 109056 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-03-19 | 2020-08-21 | 109059 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-05-21 | 2020-08-21 | 115550 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-10-01 | 2020-11-07 | 125473 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-20 | 2021-08-13 | 139737 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-05-19 | 2022-12-22 | 161003 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161964 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-06-30 | 2023-04-28 | 163927 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179294 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2023-10-05 | 2024-01-11 | 206395 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 226936 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227468 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2018-10-23 | 2019-04-27 | 65494 |
| TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2020-04-16 | 2020-08-19 | 112388 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2020-05-29 | 2020-06-04 | 116150 |
| TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2021-01-22 | 2021-03-11 | 132273 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |